Perspective Therapeutics, Inc. (NYSE: ISR) - quick read on what's happening inside
Straight to the point: the company is advancing multiple clinical programs and investing heavily in manufacturing capacity and R&D. That progress is driving a sharp increase in expenses and cash burn, though the ba...